Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07446738

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a prospective, multicenter real-world observational study designed to describe post-operative outcomes, quality of life, disease control, recurrence-related characteristics, economic burden and post-operative treatment patterns in Chinese patients with CRSwNP undergoing endoscopic sinus surgery (ESS).

Official title: PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

146

Start Date

2026-03-19

Completion Date

2027-10-21

Last Updated

2026-09-25

Healthy Volunteers

No

Interventions

OTHER

Other: Routine Clinical Care for CRSwNP

Patients will receive standard medical care as determined by the treating physician according to routine clinical practice at each site. No treatment assignment will be made as part of the study.

Locations (21)

The Seventh Affiliated Hospital Sun Yat-sen University

Guangzhou, Guangdong, China

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China

QiLu Hospital of Shandong University

Jinan, Shandong, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Haikou, China

Research Site

Kunming, China

Research Site

Nanchang, China

Research Site

Nanjing, China

Research Site

Nanning, China

Research Site

Qingdao, China

Research Site

Shanghai, China

Research Site

Shenzhen, China

Research Site

Ürümqi, China

Research Site

Wuhan, China

Research Site

Wuhan, China

Research Site

Xiamen, China